Journal of Ophthalmic Inflammation and Infection (Jun 2017)

Neomycin, polymyxin B, and dexamethasone allergic reactions following periocular surgery

  • Nicholas A. Moore,
  • Craig N. Czyz,
  • Tracy D. Carter,
  • Jill A. Foster,
  • Kenneth V. Cahill

DOI
https://doi.org/10.1186/s12348-017-0133-4
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 4

Abstract

Read online

Abstract Background The aim of this study was to evaluate the rate of periocular allergic skin reactions to topical neomycin, polymyxin B, and dexamethasone (NPD) ophthalmic ointment. Methods A consecutive patient prospective study was performed. A total of 522 patients who had a procedure involving incision of the periocular skin with subsequent postoperative application of NPD ophthalmic ointment were included. Patients were evaluated for signs of allergy at 1 week postoperatively or prior if the patient had complaints. A periocular allergic reaction was defined as any periocular skin pruritus, erythema, edematous papules, vesicles, or plaques at the site of ointment application beyond that of the typical postprocedure presentation. The patients continued to be monitored for 30 days postoperatively. Results Of the 522 patients who completed the study, eight (1.5%) had a definitive periocular allergic contact dermatitis to the NPD ophthalmic ointment. Allergic presentation ranged from postoperative day 3 to 14. Conclusions The rate of periocular allergic reactions to NPD ophthalmic ointment is significantly lower than reported in the literature for other topical preparations of neomycin and polymyxin B. The low rate of allergy in this study suggests that NPD ophthalmic ointment can safely be applied to the periocular skin with a very minimal risk of inciting an allergic reaction.